A new Case Study maps ophthalmology AI research against workforce capacity and blindness burden, showing how concentrated AI development in high-income countries could worsen global health inequities. Learn more: https://nejm.ai/4aPRgqG #ArtificialIntelligence #AIinMedicine
NEJM AI
@ai.nejm.org
NEJM AI, a new monthly journal from the publisher of @nejm.org, explores the cutting-edge applications of artificial intelligence and machine learning in clinical medicine. Online at ai.nejm.org.
A new study evaluates Flourish, a mobile app using generative AI to deliver personalized, strengths-based well-being support to young adults through an AI well-being coach, in a 6-week randomized trial across three U.S. campuses. Learn more: https://nejm.ai/3TJ9iVy
Before a drug reaches patients, it has to clear a critical gate. In the latest episode of the NEJM AI Grand Rounds podcast, Brandon Rice of Weave explains why the Investigational New Drug (IND) process shapes everything that follows. Learn more: https://nejm.ai/ep44
A new Perspective examines the impact of AI on national health care expenditures, arguing that near-term cost reductions will depend heavily on policy and management choices rather than the technology alone. Learn more: https://nejm.ai/4f3PfcX #ArtificialIntelligence #AIinMedicine
Drug development has embraced cutting-edge science. The paperwork often hasn’t. In the latest episode of the NEJM AI Grand Rounds podcast, Brandon Rice of Weave explains why regulatory workflows are a major opportunity for AI. Full episode: https://nejm.ai/ep44
A new Perspective examines why pathology, despite being foundational to modern diagnostics, has seen limited clinical adoption of AI-enabled imaging tools. It outlines barriers and pathways for AI-assisted workflows and clinical trial applications. Learn more: https://nejm.ai/44xQhI1
Curiosity came first. Entrepreneurship came later. In the latest episode of the NEJM AI Grand Rounds podcast, Brandon Rice traces the path from building computers as a kid to building Weave. Listen to the full episode: https://nejm.ai/ep44
Perspective by Kushal T. Kadakia, MD, MSc, and Harlan M. Krumholz, MD, SM: Adoption of Artificial Intelligence–Based End Points — A New Era for Clinical Trials https://nejm.ai/4wkloTl
Original Article by O.L. Saldanha et al.: Privacy-Preserving Surgical Video Analysis with Swarm Learning — Results from a Multinational Appendectomy Cohort https://nejm.ai/44Ap0V9
Case Study by A.S. Liang et al.: SmartAlert — Implementing Machine Learning–Driven Clinical Decision Support for Inpatient Laboratory Utilization Reduction https://nejm.ai/4ezJxzb
An AI-derived and validated machine-learning system appeared to predict the risk of Hirschsprung disease with the use of genetic and demographic data from participants in China. Learn more in a correspondence published in NEJM: https://nej.md/4xVlzWE
A new Perspective examines the first European Medicines Agency and U.S. Food and Drug Administration endorsements of an AI-enabled clinical trial end point tool — AIM-NASH — and explores implications for evidence generation. Learn more: https://nejm.ai/4wkloTl
A new study introduces a decentralized, privacy-preserving pipeline that combines weakly supervised deep learning with Swarm Learning to predict patient-level labels from laparoscopic appendectomy videos. Learn more about this approach: https://nejm.ai/44Ap0V9
In the latest episode of the NEJM AI Grand Rounds podcast, Brandon Rice of Weave discusses the challenge of organizing scientific knowledge, communicating with regulators, and navigating processes that can span more than a decade. Listen now: https://nejm.ai/ep44
SmartAlert — a machine learning–driven clinical decision support system targeting inpatient complete blood count utilization — reduced repetitive testing. Success depended on end-user engagement, implementation, and governance. Learn more: https://nejm.ai/4ezJxzb
Datasets, Benchmarks, and Protocols by M. Baharoon et al.: ReXGroundingCT: A 3D Chest CT Dataset for Segmentation of Findings from Free-Text Reports https://nejm.ai/4giw8N6 #ArtificialIntelligence #AIinMedicine
The future isn’t just clinician empowerment. It’s patient empowerment. In the latest episode of the NEJM AI Grand Rounds podcast, Dr. Karan Singal sees AI helping people navigate care. Hear more from Dr. Singal in the full episode: https://nejm.ai/ep43 #ArtificialIntelligence #AIinMedicine
Case Study by A. Jaech et al.: LLM-Assisted Reanalysis of Unsolved Rare Disease Genomes Increases Diagnostic Yield https://nejm.ai/4eMh8pu #ArtificialIntelligence #AIinMedicine
Editorial by Samuel G. Finlayson, MD, PhD, and Heidi L. Rehm, PhD: When Genomic Reanalysis Leaves the Laboratory — Clinical Genetics in the Age of Consumer AI https://nejm.ai/4vVYCAY #ArtificialIntelligence #AIinMedicine
Sometimes the problem isn't the model. It's the environment around it. In the latest episode of the NEJM AI Grand Rounds podcast, Dr. Karan Singal explains why workflow design matters. Listen now: https://nejm.ai/ep43 #ArtificialIntelligence #AIinMedicine
ReXGroundingCT is the first publicly available manually annotated dataset to link free-text radiology findings with 3D segmentations in chest CT scans, enabling research in grounded radiology report generation. Learn more: https://nejm.ai/4giw8N6
A new Case Study evaluates an LLM–assisted genomic reanalysis workflow that integrates clinician notes, Human Phenotype Ontology terms, and filtered variant data to generate diagnostic hypotheses for expert review. Learn more: https://nejm.ai/4eMh8pu
What if better models reduce — not increase — the value of traditional oversight? In the latest episode of the NEJM AI Grand Rounds podcast, Dr. Karan Singal discusses findings that challenge assumptions. Listen to the full episode: https://nejm.ai/ep43 #ArtificialIntelligence #AIinMedicine
A new editorial discusses whether clinical genetics is prepared for a world in which patients and families can generate rare disease analyses on their own. Full editorial: https://nejm.ai/4vVYCAY
Human + AI isn't a fixed equation. In the latest episode of the NEJM AI Grand Rounds podcast, Dr. Karan Singal describes findings showing that oversight may depend on model capability. Learn more: https://nejm.ai/ep43 #ArtificialIntelligence #AIinMedicine
What pulls someone into AI? For Dr. Karan Singal, it wasn’t code first — it was curiosity. Hear more from Dr. Singal in the latest episode of the NEJM AI Grand Rounds podcast: https://nejm.ai/ep43 #ArtificialIntelligence #AIinMedicine
Perspective by Adrian Gropper, MD: The Medical AI Assistant as Publication, Not Device — Why Peer-Reviewed, Open-Source AI Belongs in the Standard of Care https://nejm.ai/4e7q6MA #ArtificialIntelligence #AIinMedicine
Editorial by Isaac S. Kohane, MD, PhD: Guideline Machines https://nejm.ai/49QwJBF #ArtificialIntelligence #AIinMedicine
A new Perspective proposes that open-weight, peer-reviewed retrieval-augmented medical artificial intelligence assistants, used with physician review, may be better understood as published clinical methodologies rather than regulated devices. Learn more: https://nejm.ai/4e7q6MA
A new editorial by Isaac S. Kohane, MD, PhD, discusses the role of AI in clinical guidelines. Full editorial: https://nejm.ai/49QwJBF #ArtificialIntelligence #AIinMedicine